We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Replimune Group
REPL
$724M
| $135K | ﹤0.01% |
16,581
-80,253
| -83% | -$658K |
|
2252
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
| $135K | ﹤0.01% |
1,072
+772
| +257% | +$90.9K |
|
|
HERE
2253
Here Group Ltd
HERE
$103M
| $133K | ﹤0.01% |
+32,639
| New | +$104K |
|
|
NBP
2254
NovaBridge Biosciences American Depositary Shares
NBP
$206M
| $132K | ﹤0.01% |
+71,088
| New | +$131K |
|
|
RVPH
2255
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $132K | ﹤0.01% |
1,743
-212
| -11% | -$16.8K |
|
2256
ClearPoint Neuro
CLPT
$438M
| $131K | ﹤0.01% |
+19,276
| New | +$135K |
|
2257
Asure Software
ASUR
$222M
| $130K | ﹤0.01% |
16,731
-86,818
| -84% | -$779K |
|
2258
DHI Group
DHX
$164M
| $129K | ﹤0.01% |
+50,548
| New | +$126K |
|
2259
InflaRx
IFRX
$250M
| $126K | ﹤0.01% |
81,819
+45,818
| +127% | +$74.9K |
|
|
MVO
2260
MV Oil Trust
MVO
$6.85M
| $126K | ﹤0.01% |
+11,785
| New | +$130K |
|
|
IMA
2261
ImageneBio Inc
IMA
$63.7M
| $126K | ﹤0.01% |
+7,391
| New | +$135K |
|
2262
Roadzen
RDZN
$106M
| $125K | ﹤0.01% |
+19,216
| New | +$114K |
|
2263
Automatic Data Processing
ADP
$102B
| $125K | ﹤0.01% |
+500
| New | +$122K |
|
2264
ADMA Biologics
ADMA
$1.97B
| $123K | ﹤0.01% |
+18,597
| New | +$102K |
|
|
SWN
2265
DELISTED
Southwestern Energy Company
SWN
| $123K | ﹤0.01% |
+16,192
| New | +$110K |
|
|
VMEO
2266
DELISTED
Vimeo
VMEO
| $120K | ﹤0.01% |
29,293
-724,929
| -96% | -$3.09M |
|
2267
Outset Medical
OM
$80.1M
| $119K | ﹤0.01% |
3,563
+2,214
| +164% | +$112K |
|
2268
Pulse Biosciences
PLSE
$2.27B
| $118K | ﹤0.01% |
13,500
-13,032
| -49% | -$120K |
|
2269
ProFrac Holding
ACDC
$725M
| $117K | ﹤0.01% |
14,000
-118,981
| -89% | -$914K |
|
2270
Sensus Healthcare
SRTS
$49.7M
| $116K | ﹤0.01% |
+30,655
| New | +$111K |
|
2271
PUT
PayPal
PYPL
$49.5B
| $116K | ﹤0.01% |
1,800
-137,100
| -99% | -$8.41M |
|
2272
CytomX Therapeutics
CTMX
$708M
| $114K | ﹤0.01% |
52,289
-310,987
| -86% | -$574K |
|
2273
American Express
AXP
$226B
| $114K | ﹤0.01% |
500
-2,203
| -82% | -$457K |
|
2274
Nexa Resources
NEXA
$1.71B
| $114K | ﹤0.01% |
+15,867
| New | +$111K |
|
2275
Amtech Systems
ASYS
$269M
| $113K | ﹤0.01% |
+20,797
| New | +$93.7K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.